+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Growth Opportunities for Global Antimicrobial Technologies Enabled by COVID-19

  • Report

  • 78 Pages
  • August 2022
  • Region: Global
  • Frost & Sullivan
  • ID: 5656011

Innovation Culture and Growth Strategies Catalyzed to Prevent Infections

Antimicrobial technology has previously seen wide adoption in antimicrobial additives, coatings, and films in consumer health applications. However, with the emergence of COVID-19, the demand for antimicrobial technology has driven innovations, such as graphene nanoparticles (NPs), photocatalytic additives, and antimicrobial polymer nanomaterials, in developing high-temperature resistance, non-toxic antimicrobial disinfectants, and long-lasting antimicrobial technology adoption in consumer health, building and construction, automotive, and consumer goods applications. Antimicrobial technology materials include antimicrobial polymers; composites, metal-based antimicrobial agents; nanomaterials; natural-based antimicrobial agents; antimicrobial peptides (AMPs); and other materials, such as phenolics, amidines, and biguanides.

Due to their stable structure, metal ions and metal-oxide ions have found use in medical and food packaging applications. The use of ultra-thin two-dimensional materials like black phosphorus and graphene on antimicrobial surfaces has been a focus of technology development initiatives following the outbreak of COVID-19. In addition to antimicrobial surfaces, implants, medical devices, food packaging, building and construction materials, and textiles have all experienced a spike in interest for antimicrobial coatings. The need for active packaging that exhibits high antimicrobial features for food and personal care applications following COVID-19 has prompted industry stakeholders and researchers to continue pursuing their work with natural antimicrobials such as chitin-chitosan and peptides to develop biodegradable, safe, yet high-performance antimicrobial films.

The research will answer the following questions:

  • What factors will drive antimicrobial technology adoption post COVID-19?
  • What challenges and impediments restrain antimicrobial technology adoption?
  • What initiatives are industry participants undertaking to accelerate adoption across industries?
  • What previous challenges does antimicrobial technology adoption across applications address?
  • What growth potential exists for commercializing antimicrobial technologies across industries?


Table of Contents

1. Strategic Imperatives
  • Why Is It Increasingly Difficult to Grow? The Strategic Imperative 8™: Factors Creating Pressure on Growth
  • The Strategic Imperative 8™
  • The Impact of the Top 3 Strategic Imperatives on Antimicrobial Technologies Enabled by COVID-19
  • Growth Opportunities Fuel the Growth Pipeline Engine™
  • Research Methodology
2. Research Scope and Segmentation
  • Research Context and Key Questions the Study Will Answer
  • Research Segmentation
3. Research Summary
  • Technology Dashboard
  • Impact of COVID-19 on the Antimicrobial Technologies Landscape
  • COVID-19 Drives Interest in Antimicrobial Technologies across Regions
  • Key Findings
4. Growth Opportunity Analysis: Impact of COVID-19 on Antimicrobial Technologies
  • COVID-19 Has Resulted in an Unprecedented Demand for Antimicrobial Technologies
  • Accelerated AMR Risk and Infection Spread Propelled Antimicrobial Use in Emerging Markets Pre- and During COVID-19
  • Technologies to Accommodate Antimicrobial Features in Various Applications
  • Metal Ions, Polymers, Naturals, AMPs, and Nanoantimicrobials Could Act as Disruptors to Mitigate Infections
  • Technologies Could Solve Existing AMR Challenges Post-COVID-19
  • Mode of Action of Antimicrobials Defines Clinical Efficacy via Syntheses
  • Antimicrobials Pave the Way for a New Application Landscape beyond Healthcare
  • Regulatory Aspects Make High-performance Antimicrobial Commercialization Time-consuming
5. Technology Assessment: Antimicrobial Technologies
  • Metal Ions, Especially Copper and Ag, Help Create New Antimicrobial Technologies
  • Interest in Metal and Metal-oxide Ion Adoption as an Antimicrobial for Their Stable Structure
  • Nanomaterials Provide Multiple Bactericidal Pathways to Combat Microbes and Infections
  • Antimicrobial Nanomaterials for High-performance Solutions
  • Food Quality and Safety Awareness Create Demand for Natural Antimicrobials
  • Interest in Use of Natural Antimicrobial Materials for Degradable Antimicrobial Technology
  • The Multifaceted Nature of AMPs Drives Their Long-term Applicability
  • AMP Adoption Is Increasing in Healthcare and Food Packaging Applications
  • Antimicrobial Polymers Have Proven Capabilities to Protect Against the Negative Impact of Pathogenic Microorganisms
  • Simplifying Antimicrobial Polymer Fabrication and Application Processes
  • To Evaluate the Effect of Antimicrobial Susceptibility on Outcomes, Benchmarking Key Performance Indicators Is Pivotal
  • Antimicrobial Agents’ Relevance in Various Industrial Sectors
6. Innovation Ecosystem
  • Commercialized Metal-ion Antimicrobial Technologies
  • High-performance Antimicrobial Coating Development Using Metal Ions
  • Nanomaterials for Cost-efficient, High-performance Antimicrobial Technology Development
  • Studies Focusing on Antimicrobial Nanomaterial Adoption in Food and Energy Applications
  • Increase in Degradable Antimicrobial Film Development
  • Stakeholders Investigating the Potential Adoption of Antimicrobial Peptides for Food Packaging
  • High Interest in Research Studies on Antimicrobial Polymers in APAC
  • Antimicrobial Coatings Remain an Area of High R&D
7. IP Analysis
  • Steady Rise in Research Studies Related to Antimicrobial Technologies
  • Metal Ions and Natural Antimicrobial Technologies Lead in IP Filing across the Globe
  • US and European Patent Offices Show Steady Rise in IP Filings in Last 5 Years
  • Natural Antimicrobials Are Gaining IP Focus Because of Increased Interest in Developing Environment-friendly Technologies
8. Funding and Investment Analysis
  • Investors Bet Big on Antimicrobials to Reinforce Health and Safety During the Pandemic
  • Funding Is Predominantly Inclined towards New Product Innovation
  • Healthcare Companies Are Prominent Beneficiaries to Investigate Enhanced Antimicrobials for Combatting AMR
  • Antimicrobial Spending to Escalate to Eliminate Superbug Threats
  • Government Initiatives and Funding and Private Funding Encourage Cost-efficient Antimicrobial Technology Development
  • Accelerators and Incubators Expedite Material and Digitization Initiative Growth
9. Growth Opportunity Universe
  • Growth Opportunity 1: Ultra-thin, Durable, High-performance Antimicrobial Technology Development
  • Growth Opportunity 2 Nanomaterial Integration During Fabrication for Cost-efficient and High-performance Antimicrobial Technologies
  • Growth Opportunity 3: R&D Activities to Use Metal and Metal-oxide Ions to Develop Self-sanitizing Technology
  • Growth Opportunity 4: Digital Interventions on Antimicrobial Stewardship Can Drive New Product Development
10. Appendix
  • Technology Readiness Levels (TRL): Explanation
11. Next Steps
  • Your Next Steps
  • Legal Disclaimer